REPLIGEN CORP (RGEN) Return on equity 2016–2025
REPLIGEN CORP (RGEN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
2.3%FY2025 · since FY2016: 6.9% → 2.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2.3% | +3.6 pp |
| FY2024 | -1.3% | -3.1 pp |
| FY2023 | 1.8% | -7.9 pp |
| FY2022 | 9.7% | +2.4 pp |
| FY2021 | 7.3% | +3.4 pp |
| FY2020 | 3.9% | +1.9 pp |
| FY2019 | 2.0% | -0.7 pp |
| FY2018 | 2.7% | -2.1 pp |
| FY2017 | 4.8% | -2.1 pp |
| FY2016 | 6.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice